Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New eye drop could heal corneal wounds that Won't close

NCT ID NCT07519902

First seen May 05, 2026 · Last updated May 23, 2026 · Updated 4 times

Summary

This study tests an eye drop containing a human nerve growth factor (cenegermin) to see if it can heal persistent corneal epithelial defects — stubborn wounds on the clear front part of the eye that haven't healed with standard treatments. About 150 adults with such wounds will receive either the active drop or a placebo for up to 8 weeks, and doctors will check if the cornea is fully healed at 4 and 8 weeks. The goal is to find a safe and effective way to close these hard-to-treat eye injuries.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERSISTENT CORNEAL EPITHELIAL DEFECT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-••••

Locations

  • Houston Eye Associates (HEA)

    Houston, Texas, 77030, United States

  • Midwest Vision Research Foundation

    Chesterfield, Missouri, 63017, United States

  • Ophthalmic Consultants of Boston

    Boston, Massachusetts, 02114, United States

  • The Eye Institute of Utah

    Salt Lake City, Utah, 84107, United States

Conditions

Explore the condition pages connected to this study.